Kiora Pharmaceuticals (KPRX) stock jumped 17% pre-market after securing a $24 million private placement led by Perceptive Advisors and ADAR1 Capital Management. The financing offers $5 million upfront to support R&D. This boost comes as the company advances its retinitis pigmentosa treatment into the patient dosing phase.